How the incoming administration could impact FTC’s approach to pharma M&A
Pharma leaders hoping for a friendlier merger environment after the Trump administration grabs the keys to the White House ...
STAT3d
Don’t expect Novo-Catalent merger investigation to fizzle out under the new Trump administration
Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.